Allogene Therapeutics Inc (ALLO)
2.49
+0.03
(+1.22%)
USD |
NASDAQ |
May 31, 16:00
2.50
+0.01
(+0.40%)
After-Hours: 20:00
Allogene Therapeutics Total Assets (Quarterly): 586.35M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 586.35M |
December 31, 2023 | 642.84M |
September 30, 2023 | 712.33M |
June 30, 2023 | 770.97M |
March 31, 2023 | 746.87M |
December 31, 2022 | 821.58M |
September 30, 2022 | 887.57M |
June 30, 2022 | 947.64M |
March 31, 2022 | 964.63M |
December 31, 2021 | 1.051B |
September 30, 2021 | 1.079B |
June 30, 2021 | 1.127B |
Date | Value |
---|---|
March 31, 2021 | 1.179B |
December 31, 2020 | 1.228B |
September 30, 2020 | 1.222B |
June 30, 2020 | 1.259B |
March 31, 2020 | 688.52M |
December 31, 2019 | 717.80M |
September 30, 2019 | 695.54M |
June 30, 2019 | 734.00M |
March 31, 2019 | 749.37M |
December 31, 2018 | 773.86M |
September 30, 2018 | 435.24M |
June 30, 2018 | 298.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
586.35M
Minimum
Mar 2024
1.259B
Maximum
Jun 2020
903.07M
Average
854.58M
Median
Total Assets (Quarterly) Benchmarks
ANI Pharmaceuticals Inc | 914.52M |
Vaxart Inc | 88.67M |
Agenus Inc | 256.56M |
BioCryst Pharmaceuticals Inc | 467.89M |
Stereotaxis Inc | 39.45M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 124.98M |
Shareholders Equity (Quarterly) | 461.37M |
Current Ratio | 12.80 |